10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0001493152-22-032118`
Period End Date	20220930
Filing Date	20221114
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 63 Income Statement 80 Cash Flow Statement 77 Stockholders Equity 37

Balance Sheet 63 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$29.76M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$32.09M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$6.99M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$16.18M	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableRelatedPartiesCurrent`	$1.64M	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableRelatedPartiesCurrent`	-	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$805.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$304.00K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	$3.60M	USD	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	$41.15M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$50.21M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.05M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$118.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$866.00K	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$149.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.01M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.50M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	47.99M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	48.08M	shares	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.97M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	47.99M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.32M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	48.08M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$2.14M	USD	Point-in-time
Total assets	`Assets`	$46.28M	USD	Point-in-time
Total assets	`Assets`	$57.70M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$957.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$198.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.77M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$438.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$171.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$37.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.90M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$673.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$695.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$112.00K	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	$35.00K	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	-	USD	Point-in-time
Commitments and contingencies (Notes 12, 13, and 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series B Convertible Preferred Stock, stated value $1,000 per share, 713 and 715 issued and outstanding, respectively	`PreferredStockValue`	$715.00K	USD	Point-in-time
Series B Convertible Preferred Stock, stated value $1,000 per share, 713 and 715 issued and outstanding, respectively	`PreferredStockValue`	$713.00K	USD	Point-in-time
Common Stock, par value $0.001 per share, authorized 350,000,000 shares: 48,082,275, and 47,994,672, issued and outstanding, respectively	`CommonStockValue`	$48.00K	USD	Point-in-time
Common Stock, par value $0.001 per share, authorized 350,000,000 shares: 48,082,275, and 47,994,672, issued and outstanding, respectively	`CommonStockValue`	$48.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$417.22M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$418.09M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-361.10M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-376.16M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$70.97M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$53.30M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$65.53M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$48.78M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$56.88M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$61.29M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$42.70M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$62.05M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$46.28M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$57.70M	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs - US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$85.00K	USD	3 Qtrs
Clinical treatment programs - US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$33.00K	USD	1 Quarter
Clinical treatment programs - US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$85.00K	USD	3 Qtrs
Clinical treatment programs - US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$21.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$674.00K	USD	3 Qtrs
Production costs	`ManufacturingCosts`	-	USD	1 Quarter
Production costs	`ManufacturingCosts`	-	USD	3 Qtrs
Production costs	`ManufacturingCosts`	$157.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.01M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.88M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.75M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.37M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$6.05M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.80M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.17M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$9.57M	USD	3 Qtrs
Total Costs and Expenses	`CostsAndExpenses`	$6.54M	USD	1 Quarter
Total Costs and Expenses	`CostsAndExpenses`	$11.48M	USD	3 Qtrs
Total Costs and Expenses	`CostsAndExpenses`	$3.96M	USD	1 Quarter
Total Costs and Expenses	`CostsAndExpenses`	$14.45M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-11.39M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-3.93M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-6.52M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-14.37M	USD	3 Qtrs
Loss on investments	`GainLossOnInvestments`	-	USD	3 Qtrs
Loss on investments	`GainLossOnInvestments`	$-1.77M	USD	3 Qtrs
Loss on investments	`GainLossOnInvestments`	$-365.00K	USD	1 Quarter
Loss on investments	`GainLossOnInvestments`	-	USD	1 Quarter
Interest and other income, net	`OtherNonoperatingIncomeExpense`	$-20.00K	USD	1 Quarter
Interest and other income, net	`OtherNonoperatingIncomeExpense`	$100.00K	USD	3 Qtrs
Interest and other income, net	`OtherNonoperatingIncomeExpense`	$172.00K	USD	1 Quarter
Interest and other income, net	`OtherNonoperatingIncomeExpense`	$296.00K	USD	3 Qtrs
Interest expense and other finance costs	`InterestExpense`	-	USD	1 Quarter
Interest expense and other finance costs	`InterestExpense`	-	USD	3 Qtrs
Interest expense and other finance costs	`InterestExpense`	$67.00K	USD	3 Qtrs
Interest expense and other finance costs	`InterestExpense`	-	USD	1 Quarter
Extinguishment of financing obligation and note payable	`GainsLossesOnExtinguishmentOfDebt`	$-2.70M	USD	3 Qtrs
Extinguishment of financing obligation and note payable	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Extinguishment of financing obligation and note payable	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Extinguishment of financing obligation and note payable	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Gain on sale of fixed assets	`GainLossOnDispositionOfAssets1`	-	USD	3 Qtrs
Gain on sale of fixed assets	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Gain on sale of fixed assets	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Gain on sale of fixed assets	`GainLossOnDispositionOfAssets1`	$216.00K	USD	3 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-1.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-51.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-35.00K	USD	3 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-22.00K	USD	3 Qtrs
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-328.00K	USD	1 Quarter
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-72.00K	USD	1 Quarter
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-542.00K	USD	3 Qtrs
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-749.00K	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-15.06M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-13.28M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-3.83M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-6.38M	USD	1 Quarter
Reclassification adjustment for realized investment loss	`ReclassificationAdjustmentForRealizedInvestmentLost`	$126.00K	USD	3 Qtrs
Reclassification adjustment for realized investment loss	`ReclassificationAdjustmentForRealizedInvestmentLost`	-	USD	3 Qtrs
Reclassification adjustment for realized investment loss	`ReclassificationAdjustmentForRealizedInvestmentLost`	$101.00K	USD	1 Quarter
Reclassification adjustment for realized investment loss	`ReclassificationAdjustmentForRealizedInvestmentLost`	-	USD	1 Quarter
Change in unrealized loss on marketable securities available for sale	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-104.00K	USD	1 Quarter
Change in unrealized loss on marketable securities available for sale	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-329.00K	USD	3 Qtrs
Change in unrealized loss on marketable securities available for sale	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	1 Quarter
Change in unrealized loss on marketable securities available for sale	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.82M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-6.38M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-5.91M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.85M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-15.06M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-13.48M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.83M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.74M	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasic`	$-0.31	USD	3 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasic`	$-0.28	USD	3 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasic`	$-0.08	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasic`	$-0.13	USD	1 Quarter
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfSharesIssuedBasic`	48.08M	shares	1 Quarter
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfSharesIssuedBasic`	47.16M	shares	3 Qtrs
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfSharesIssuedBasic`	48.04M	shares	3 Qtrs
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfSharesIssuedBasic`	47.85M	shares	1 Quarter

Cash Flow Statement 77 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-15.06M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-13.28M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.83M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.38M	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$29.00K	USD	3 Qtrs
Depreciation of property and equipment	`Depreciation`	$484.00K	USD	3 Qtrs
Redeemable warrants valuation adjustment	`RedeemableWarrantsValuationAdjustment`	$-22.00K	USD	3 Qtrs
Redeemable warrants valuation adjustment	`RedeemableWarrantsValuationAdjustment`	$-35.00K	USD	3 Qtrs
Extinguishment of financing obligation and note payable	`ExtinguishmentOfFinancingObligationAndNotePayables`	$2.70M	USD	3 Qtrs
Extinguishment of financing obligation and note payable	`ExtinguishmentOfFinancingObligationAndNotePayables`	-	USD	3 Qtrs
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$57.00K	USD	3 Qtrs
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$97.00K	USD	3 Qtrs
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$116.00K	USD	Annual
Changes in ROU assets	`IncreaseDecreaseinRightofUseAssets`	$35.00K	USD	3 Qtrs
Changes in ROU assets	`IncreaseDecreaseinRightofUseAssets`	$-717.00K	USD	3 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	3 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$216.00K	USD	3 Qtrs
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$-749.00K	USD	3 Qtrs
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$-542.00K	USD	3 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$792.00K	USD	3 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$1.32M	USD	3 Qtrs
Gain (Loss) on sale of marketable securities	`MarketableSecuritiesGainLoss`	$-126.00K	USD	3 Qtrs
Gain (Loss) on sale of marketable securities	`MarketableSecuritiesGainLoss`	$-1.77M	USD	3 Qtrs
Amortization of finance and debt issuance costs	`AmortizationOfFinancingCosts`	$47.00K	USD	3 Qtrs
Amortization of finance and debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-6.00K	USD	3 Qtrs
Funds Receivable from New Jersey net operating loss	`IncreaseDecreaseInOtherReceivables`	$-1.09M	USD	3 Qtrs
Funds Receivable from New Jersey net operating loss	`IncreaseDecreaseInOtherReceivables`	$-1.64M	USD	3 Qtrs
Prepaid expenses and other current assets and other non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-64.00K	USD	3 Qtrs
Prepaid expenses and other current assets and other non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$500.00K	USD	3 Qtrs
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$717.00K	USD	3 Qtrs
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-35.00K	USD	3 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$73.00K	USD	3 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	-	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-14.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$758.00K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-80.00K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.33M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.04M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.22M	USD	3 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$9.08M	USD	3 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$849.00K	USD	3 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$1.61M	USD	3 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$1.66M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$34.00K	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$245.00K	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$300.00K	USD	3 Qtrs
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$96.00K	USD	3 Qtrs
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$444.00K	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-995.00K	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$7.62M	USD	3 Qtrs
Payment of financing obligation	`PaymentOfFinancingObligation`	$4.73M	USD	3 Qtrs
Payment of financing obligation	`PaymentOfFinancingObligation`	-	USD	3 Qtrs
Financing obligation payments	`RepaymentsOfLongTermDebt`	$122.00K	USD	3 Qtrs
Financing obligation payments	`RepaymentsOfLongTermDebt`	-	USD	3 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$80.00K	USD	3 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$12.92M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$8.06M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$80.00K	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.15M	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.33M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$32.09M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$29.76M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$38.50M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$37.35M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$32.09M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$29.76M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$38.50M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$37.35M	USD	Point-in-time
Operating lease-Right of Use Assets	`OperatingLeaserightOfUseAssets`	$717.00K	USD	3 Qtrs
Operating lease-Right of Use Assets	`OperatingLeaserightOfUseAssets`	-	USD	3 Qtrs
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-329.00K	USD	3 Qtrs
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-1.17M	USD	3 Qtrs
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$7.00K	USD	3 Qtrs
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$2.00K	USD	3 Qtrs

Stockholders Equity 37 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$70.97M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$53.30M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$65.53M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$48.78M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$56.88M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$61.29M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$42.70M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$62.05M	USD	Point-in-time
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$242.00K	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$314.00K	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$480.00K	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$275.00K	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$526.00K	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$275.00K	USD	1 Quarter
Net Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.82M	USD	1 Quarter
Net Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-6.38M	USD	1 Quarter
Net Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-5.91M	USD	1 Quarter
Net Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.85M	USD	1 Quarter
Net Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-15.06M	USD	3 Qtrs
Net Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-13.48M	USD	3 Qtrs
Net Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.83M	USD	1 Quarter
Net Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.74M	USD	1 Quarter
Common stock issuances, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$25.00K	USD	1 Quarter
Common stock issuances, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$30.00K	USD	1 Quarter
Common stock issuances, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$55.00K	USD	1 Quarter
Common stock issuances, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$12.89M	USD	1 Quarter
Series B preferred shares converted to common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	1 Quarter
Series B preferred shares converted to common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	1 Quarter
Cashless Warrant Conversion	`CashlessWarrantValueConversion`	-	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$70.97M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$53.30M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$65.53M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$48.78M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$56.88M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$61.29M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$42.70M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$62.05M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.